factual
Cancer drug cost-per-QALY can approach or exceed $1 million
Because cancer drugs offer marginal benefits in ideal settings while costing enormous amounts, cost-per-quality-adjusted-life-year figures reach stratospheric levels—around $900,000 for some colon cancer drugs and effectively infinite for drugs like Aflibercept that cost more than alternatives while delivering nothing more—far above the $60-70k UK ceiling or the $200-250k upper limit some US economists endorse.
factualpending
Speaker
Vinay PrasadEvidence Quote
“We see some drugs that may even be infinite, because they cost more than alternatives and they deliver nothing more, such as Aflibercept in colon cancer.”
Created: 6/13/2026, 12:28:36 AM
Your notes
Loading notes...